VIVO logo

Meridian Bioscience (VIVO) Retained Earnings

Annual Retained Earnings

$223.16 M
+$42.46 M+23.50%

September 30, 2022

Summary

Performance

1-Year Change

+23.5%

3-Year Change

+253.62%

5-Year Change

+375.59%

15-Year Change

+375.59%

VIVO Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$223.16 M
VIVO annual retained earnings is currently at an all-time high

3-Year Low

$180.70 M
VIVO annual retained earnings is currently +23.50% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2022
VIVO previous annual earnings announcement was published on Sep 30, 2022

Next Annual Earnings Report Date

N/A
VIVO next annual earnings announcement has not yet been scheduled

OtherVIVObalance sheetmetrics:

Annual Shareholders Equity

$368.06 M
VIVO annual stockholders equity is $368.06 million

Annual Working Capital

$152.65 M
VIVO annual working capital is $152.65 million

Annual Total Assets

$463.10 M
VIVO annual total assets is $463.10 million

Annual Total Liabilities

$95.04 M
VIVO annual total liabilities is $95.04 million

Quarterly Retained Earnings

$223.16 M
+$5.71 M+2.62%

September 30, 2022

Summary

Performance

3-Month Change

+2.62%

1-Year Change

+23.5%

3-Year Change

+253.62%

5-Year Change

+375.59%

VIVO Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$224.79 M
VIVO quarterly retained earnings is currently -0.73% below its historical high of $224.79 million

3-Year Low

$196.04 M
VIVO quarterly retained earnings is currently +13.83% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
VIVO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
VIVO next earnings announcement has not yet been scheduled

OtherVIVObalance sheetmetrics:

Quarterly Shareholders Equity

$368.06 M
VIVO quarterly stockholders equity is $368.06 million

Quarterly Working Capital

$152.65 M
VIVO quarterly working capital is $152.65 million

Quarterly Total Assets

$463.10 M
VIVO quarterly total assets is $463.10 million

Quarterly Total Liabilities

$95.04 M
VIVO quarterly total liabilities is $95.04 million

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

Annual Retained Earnings

$223.16 M
VIVO annual retained earnings is $223.16 million

Annual Net Income

$42.46 M
VIVO annual net profit is $42.46 million

Annual Dividends Paid

-
VIVO annual dividends paid value is unknown

VIVO Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+23.5%+23.5%
3 y3 years+253.6%+253.6%
5 y5 years+375.6%+375.6%

VIVO Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-19.0%-0.7%-12.2%
5 y5-yearat high-71.7%-0.7%-70.5%
alltimeall timeat high-99.6%-0.7%-99.6%

Meridian Bioscience Retained Earnings History

DateAnnualQuarterly
Sep 2022
$223.16 M(+23.5%)
$223.16 M(+2.6%)
Jun 2022
-
$217.46 M(-3.3%)
Mar 2022
-
$224.79 M(+14.7%)
Dec 2021
-
$196.04 M(+8.5%)
Sep 2021
$180.70 M(+65.3%)
$180.70 M(+3.8%)
Jun 2021
-
$174.04 M(+7.2%)
Mar 2021
-
$162.38 M(+19.3%)
Dec 2020
-
$136.07 M(+24.5%)
Sep 2020
$109.29 M(+73.2%)
$109.29 M(+6.3%)
Jun 2020
-
$102.80 M(+36.5%)
Mar 2020
-
$75.29 M(+14.2%)
Dec 2019
-
$65.94 M(+4.5%)
Sep 2019
$63.11 M(+27.2%)
$63.11 M(+7.0%)
Jun 2019
-
$59.01 M(+9.1%)
Mar 2019
-
$54.07 M(+3.4%)
Dec 2018
-
$52.29 M(+5.4%)
Sep 2018
$49.60 M(+5.7%)
$49.60 M(+0.3%)
Jun 2018
-
$49.47 M(+3.2%)
Mar 2018
-
$47.94 M(-0.0%)
Dec 2017
-
$47.94 M(+2.2%)
Sep 2017
$46.92 M(-5.5%)
$46.92 M(+1.0%)
Jun 2017
-
$46.47 M(-9.8%)
Mar 2017
-
$51.51 M(+8.5%)
Dec 2016
-
$47.47 M(-4.4%)
Sep 2016
$49.63 M(-2.8%)
$49.63 M(-5.6%)
Jun 2016
-
$52.56 M(+0.6%)
Mar 2016
-
$52.22 M(+1.3%)
Dec 2015
-
$51.54 M(+1.0%)
Sep 2015
$51.05 M(+4.5%)
$51.05 M(+0.2%)
Jun 2015
-
$50.93 M(+1.5%)
Mar 2015
-
$50.17 M(+3.6%)
Dec 2014
-
$48.44 M(-0.9%)
Sep 2014
$48.87 M(+4.2%)
$48.87 M(-0.2%)
Jun 2014
-
$48.98 M(+1.1%)
Mar 2014
-
$48.45 M(+4.3%)
Dec 2013
-
$46.44 M(-1.0%)
Sep 2013
$46.89 M(+16.6%)
$46.89 M(+2.8%)
Jun 2013
-
$45.59 M(+5.3%)
Mar 2013
-
$43.28 M(+31.0%)
Dec 2012
-
$33.03 M(-17.9%)
Sep 2012
$40.21 M(+5.6%)
$40.21 M(+1.9%)
Jun 2012
-
$39.45 M(+2.0%)
Mar 2012
-
$38.66 M(+4.9%)
Dec 2011
-
$36.84 M(-3.2%)
Sep 2011
$38.06 M(-9.7%)
$38.06 M(-2.7%)
Jun 2011
-
$39.11 M(-2.3%)
Mar 2011
-
$40.01 M(-1.2%)
Dec 2010
-
$40.48 M(-4.0%)
Sep 2010
$42.18 M(-7.3%)
$42.18 M(-5.3%)
Jun 2010
-
$44.56 M(-2.8%)
Mar 2010
-
$45.84 M(-3.6%)
Dec 2009
-
$47.55 M(+4.5%)
Sep 2009
$45.52 M(+16.7%)
$45.52 M(+4.7%)
Jun 2009
-
$43.46 M(+3.9%)
Mar 2009
-
$41.83 M(+0.9%)
Dec 2008
-
$41.45 M(+6.2%)
Sep 2008
$39.02 M(+28.4%)
$39.02 M(+5.6%)
Jun 2008
-
$36.96 M(+6.2%)
Mar 2008
-
$34.82 M(+5.1%)
Dec 2007
-
$33.13 M(+9.1%)
Sep 2007
$30.38 M(+55.8%)
$30.38 M(+5.8%)
Jun 2007
-
$28.70 M(+18.9%)
Mar 2007
-
$24.14 M(+7.5%)
Dec 2006
-
$22.47 M(+15.3%)
Sep 2006
$19.49 M(+53.6%)
$19.49 M(+7.4%)
Jun 2006
-
$18.14 M(+11.4%)
Mar 2006
-
$16.28 M(+11.9%)
Dec 2005
-
$14.56 M(+14.7%)
Sep 2005
$12.69 M
$12.69 M(+16.9%)
DateAnnualQuarterly
Jun 2005
-
$10.86 M(+17.5%)
Mar 2005
-
$9.24 M(+16.6%)
Dec 2004
-
$7.93 M(+8.2%)
Sep 2004
$7.32 M(+86.3%)
$7.32 M(+24.9%)
Jun 2004
-
$5.86 M(+12.9%)
Mar 2004
-
$5.20 M(+18.3%)
Dec 2003
-
$4.39 M(+11.8%)
Sep 2003
$3.93 M(+106.7%)
$3.93 M(+15.3%)
Jun 2003
-
$3.41 M(+17.4%)
Mar 2003
-
$2.90 M(+26.2%)
Dec 2002
-
$2.30 M(+21.0%)
Sep 2002
$1.90 M(+113.1%)
$1.90 M(-7.9%)
Jun 2002
-
$2.06 M(+34.8%)
Mar 2002
-
$1.53 M(+35.4%)
Dec 2001
-
$1.13 M(+26.7%)
Sep 2001
$892.00 K(-94.0%)
$892.00 K(-46.6%)
Jun 2001
-
$1.67 M(-48.8%)
Mar 2001
-
$3.26 M(-44.0%)
Dec 2000
-
$5.82 M(-60.9%)
Sep 2000
$14.89 M(+33.8%)
$14.89 M(+7.5%)
Jun 2000
-
$13.86 M(+5.3%)
Mar 2000
-
$13.16 M(+7.9%)
Dec 1999
-
$12.20 M(+9.6%)
Sep 1999
$11.13 M(-6.5%)
$11.13 M(-13.7%)
Jun 1999
-
$12.90 M(+4.9%)
Mar 1999
-
$12.30 M(+4.2%)
Dec 1998
-
$11.80 M(-0.8%)
Sep 1998
$11.90 M(+17.8%)
$11.90 M(+0.8%)
Jun 1998
-
$11.80 M(+6.3%)
Mar 1998
-
$11.10 M(+9.9%)
Dec 1997
-
$10.10 M(0.0%)
Sep 1997
$10.10 M(+48.5%)
$10.10 M(+20.2%)
Jun 1997
-
$8.40 M(+15.1%)
Mar 1997
-
$7.30 M(+7.4%)
Dec 1996
-
$6.80 M(0.0%)
Sep 1996
$6.80 M(+83.8%)
$6.80 M(+23.6%)
Jun 1996
-
$5.50 M(+22.2%)
Mar 1996
-
$4.50 M(+25.0%)
Dec 1995
-
$3.60 M(-2.7%)
Sep 1995
$3.70 M(+164.3%)
$3.70 M(+27.6%)
Jun 1995
-
$2.90 M(+26.1%)
Mar 1995
-
$2.30 M(+43.8%)
Dec 1994
-
$1.60 M(+14.3%)
Sep 1994
$1.40 M(-6.7%)
$1.40 M(-36.4%)
Jun 1994
-
$2.20 M(+15.8%)
Mar 1994
-
$1.90 M(+26.7%)
Dec 1993
-
$1.50 M(0.0%)
Sep 1993
$1.50 M(-34.8%)
$1.50 M(-44.4%)
Jun 1993
-
$2.70 M(+3.8%)
Mar 1993
-
$2.60 M(+13.0%)
Dec 1992
-
$2.30 M(0.0%)
Sep 1992
$2.30 M(-54.0%)
$2.30 M(-58.9%)
Jun 1992
-
$5.60 M(+5.7%)
Mar 1992
-
$5.30 M(+3.9%)
Dec 1991
-
$5.10 M(+2.0%)
Sep 1991
$5.00 M(+8.7%)
$5.00 M(+6.4%)
Jun 1991
-
$4.70 M(+4.4%)
Mar 1991
-
$4.50 M(+2.3%)
Dec 1990
-
$4.40 M(-4.3%)
Sep 1990
$4.60 M(+17.9%)
$4.60 M(+7.0%)
Jun 1990
-
$4.30 M(+2.4%)
Mar 1990
-
$4.20 M(+5.0%)
Dec 1989
-
$4.00 M(+2.6%)
Sep 1989
$3.90 M(+8.3%)
$3.90 M(+2.6%)
Jun 1989
-
$3.80 M(+5.6%)
Sep 1988
$3.60 M(+5.9%)
$3.60 M(+5.9%)
Sep 1987
$3.40 M(+17.2%)
$3.40 M(+17.2%)
Sep 1986
$2.90 M(+81.3%)
$2.90 M(+81.3%)
Sep 1985
$1.60 M
$1.60 M

FAQ

  • What is Meridian Bioscience annual retained earnings?
  • What is the all time high annual retained earnings for Meridian Bioscience?
  • What is Meridian Bioscience annual retained earnings year-on-year change?
  • What is Meridian Bioscience quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Meridian Bioscience?
  • What is Meridian Bioscience quarterly retained earnings year-on-year change?

What is Meridian Bioscience annual retained earnings?

The current annual retained earnings of VIVO is $223.16 M

What is the all time high annual retained earnings for Meridian Bioscience?

Meridian Bioscience all-time high annual retained earnings is $223.16 M

What is Meridian Bioscience annual retained earnings year-on-year change?

Over the past year, VIVO annual retained earnings has changed by +$42.46 M (+23.50%)

What is Meridian Bioscience quarterly retained earnings?

The current quarterly retained earnings of VIVO is $223.16 M

What is the all time high quarterly retained earnings for Meridian Bioscience?

Meridian Bioscience all-time high quarterly retained earnings is $224.79 M

What is Meridian Bioscience quarterly retained earnings year-on-year change?

Over the past year, VIVO quarterly retained earnings has changed by +$42.46 M (+23.50%)